tert-butyl [(1S,2S)-1-benzyl-2-hydroxy-3-{[(8S,11R)-8-[(1R)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}propyl]carbamate

2-Methyl-2-propanyl [(2S,3R)-4-{[(8S,11S)-8-[(2S)-2-butanyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}-3-hydroxy-1-phenyl-2-butanyl]carbamate

2-Methyl-2-propanyl-[(2S,3R)-4-{[(8S,11S)-8-[(2S)-2-butanyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}-3-hydroxy-1-phenyl-2-butanyl]carbamat

[(2S,3R)-4-{[(8S,11S)-8-[(2S)-2-Butanyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadéca-1(15),13,16-trién-11-yl]amino}-3-hydroxy-1-phényl-2-butanyl]carbamate de 2-méthyl-2-propanyle

Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[[(8S,11S)-8-[(1S)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-13,15,16-trien-11-yl]amino]-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl este r

tert-butyl [(1S,2S)-1-benzyl-2-hydroxy-3-{[(8S,11R)-8-[(1R)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}propyl]carbamate

[1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA-1(16),13(17),14-TRIEN-11-YLAMINO)-2-HYDROXY-PROPYL] -CARBAMIC ACID TERT-BUTYL ESTER

[1-Benzyl-3-(8-Sec-Butyl-7,10-Dioxo-2-Oxa-6,9-Diaza-Bicyclo[11.2.2] Heptadeca-1(16),13(17),14-Trien-11-Ylamino)-2-Hydroxy-Propyl]-Carbamic Acid Tert-Butyl Ester

MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6

tert-Butyl ((1S,2R)-1-benzyl-2-hydroxy-3-{[(8S,11S)-8-[(1S)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}propyl)carbamate